Evaluation of two nucleophilic syntheses routes for the automated synthesis of 6-[18F]fluoro-l-DOPA.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Nuclear Medicine and Biology

• Publication date

  2017-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.nucmedbio.2016.10.007PMID 27886621
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In Vivo Biodistribution of No-Carrier-Added 6-18F-Fluoro-3,4-Dihydroxy-l-Phenylalanine (18F-DOPA), Produced by a New Nucleophilic Substitution Approach, Compared with Carrier-Added 18F-DOPA, Prepared by Conventional Electrophilic Substitution

  2015cited by this paper
• Increasing feasibility and utility of (18)F-FDOPA PET for the management of glioma.

  2015cited by this paper
• A Practical One-Pot Synthesis of Positron Emission Tomography (PET) Tracers via Nickel-Mediated Radiofluorination

  2015cited by this paper
• 6-[18F]Fluoro-L-DOPA: A Well-Established Neurotracer with Expanding Application Spectrum and Strongly Improved Radiosyntheses

  2014cited by this paper
• Neither azeotropic drying, nor base nor other additives: a minimalist approach to (18)F-labeling.

  2014cited by this paper
• Production at the Curie Level of No-Carrier-Added 6-18F-Fluoro-l-Dopa

  2013influential reference
• 18F-Fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type

  2013cited by this paper
• Usefulness of [18F]-DA and [18F]-DOPA for PET imaging in a mouse model of pheochromocytoma.

  2012cited by this paper
• Correlation of the Genotype of Paragangliomas and Pheochromocytomas with Their Metabolic Phenotype on 3,4-Dihydroxy-6-18F-Fluoro-l-Phenylalanin PET

  2012cited by this paper
• 18F-DOPA PET/CT biodistribution consideration in 107 consecutive patients with neuroendocrine tumours

  2012cited by this paper
• Hepatocellular carcinoma and gastroenteropancreatic neuroendocrine tumors: potential role of other positron emission tomography radiotracers.

  2012cited by this paper
• Lighting porphyrins and phthalocyanines for molecular photovoltaics.

  2010cited by this paper
• Nucleophilic [18F]Fluorination and subsequent decarbonylation of methoxy-substituted nitro- and halogen-benzenes activated by one or two formyl groups

  2010influential reference
• The traceless Staudinger ligation with fluorine-18: a novel and versatile labeling technique for the synthesis of PET-radiotracers

  2010cited by this paper
• Alternative solvents for electrophilic synthesis of 6‐[18F]fluoro‐L‐DOPA

  2009cited by this paper
• Three-Step, “One-Pot” Radiosynthesis of 6-Fluoro-3,4-Dihydroxy-l-Phenylalanine by Isotopic Exchange

  2009cited by this paper
• Cinchona-based phase-transfer catalysts for asymmetric synthesis.

  2009cited by this paper
• Automated synthesis of n.c.a. [18F]FDOPA via nucleophilic aromatic substitution with [18F]fluoride.

  2009cited by this paper
• 18F-FDOPA: A Multiple-Target Molecule

  2009cited by this paper
• Classification of schizophrenic patients and healthy controls using [18F] fluorodopa PET imaging.

  2008cited by this paper
• Manipulation of [11C]-5-hydroxytryptophan and 6-[18F]fluoro-3,4-dihydroxy-L-phenylalanine accumulation in neuroendocrine tumor cells.

  2008cited by this paper
• Electrophilic synthesis of 6-[18F]fluoro-L-DOPA using post-target produced [18F]F2

  2008cited by this paper
• Improved Staging of Patients With Carcinoid and Islet Cell Tumors With 18 F-Dihydroxy-Phenyl-Alanine and 11 C-5-

  2008cited by this paper
• Aspects of 6-[18F]fluoro-L-DOPA preparation

  2008cited by this paper
• Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.

  2008cited by this paper
• 6-l-18F-Fluorodihydroxyphenylalanine PET in Neuroendocrine Tumors: Basic Aspects and Emerging Clinical Applications*

  2008cited by this paper
• Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis.

  2007cited by this paper
• Positron Emission Tomography in Patients With Central Motor Disorders and in Evaluation of Brain and Other Tumors

  2007influential reference
• Effect of aldehyde and methoxy substituents on nucleophilic aromatic substitution by [18F]fluoride

  2007influential reference
• Carcinoid crisis after injection of 6-18F-fluorodihydroxyphenylalanine in a patient with metastatic carcinoid.

  2005cited by this paper
• Highly Enantioselective Synthesis of No‐Carrier‐Added 6‐[18F]Fluoro‐L‐dopa by Chiral Phase‐Transfer Alkylation

  2004cited by this paper
• Efficient synthesis of the 18F-labelled 3-O-methyl-6-[18F]fluoro-L-DOPA.

  2003cited by this paper
• Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease.

  2003cited by this paper
• PET Studies on the Function of Dopamine in Health and Parkinson's Disease

  2003cited by this paper
• Aspects of 6-[18F]fluoro-L-DOPA preparation: precursor synthesis, preparative HPLC purification and determination of radiochemical purity.

  2002cited by this paper
• Large scale production of 6-[18F]fluoro-L-DOPA in a semi-automated system

  2001cited by this paper
• Enantioselective synthesis of no-carrier added (NCA) 6-[18F]Fluoro-L-Dopa

  2001cited by this paper
• A new nucleophilic asymmetric synthesis of 6‐[18F]fluoro‐DOPA

  2001cited by this paper
• Robotic synthesis of 6-[18F]fluoro-L-dopa

  2000cited by this paper
• Robotic synthesis of 6-[18F]fluoro-L-dopa

  2000cited by this paper
• Fully automated synthesis module for the high yield one-pot preparation of 6-[]fluoro-l-DOPA

  1999cited by this paper
• 6‐[18F]Fluoro‐L‐DOPA by radiofluorodestannylation: a short and simple synthesis of a new labelling precursor

  1998cited by this paper
• A Rational Approach to Catalytic Enantioselective Enolate Alkylation Using a Structurally Rigidified and Defined Chiral Quaternary Ammonium Salt under Phase Transfer Conditions

  1997cited by this paper
• F-Dopa as an amino acid tracer to detect brain tumors.

  1996cited by this paper
• Enantioselective synthesis of 6-[fluorine-18]-fluoro-L-dopa from no-carrier-added fluorine-18-fluoride.

  1994cited by this paper
• Synthesis of 6-[18F]fluorodopamine with a synthetic unit made up of primarily sterile disposable components and operated by a master slave manipulator

  1993cited by this paper
• Regioselective radiofluorodestannylation with [18F]F2 and [18F]CH3COOF: a high yield synthesis of 6-[18F]Fluoro-L-dopa.

  1992cited by this paper
• Remote, semiautomated production of 6-[18F]fluoro-L-dopa for human studies with PET.

  1990cited by this paper
• Synthesis and purification of ?-6-[18F]fluorodopa

  1988cited by this paper
• Stereospecificity of blood-brain barrier permeability to amino acids.

  1973cited by this paper
• Sugar and amino acid transport by cells in culture--differences between normal and malignant cells.

  1972cited by this paper
• The uptake of a variety of amino acids into nuclear proteins of tumors and other tissues.

  1959cited by this paper

• Lead-it-EAZY! GMP-compliant production of [212Pb]Pb-PSC-PEG2-TOC

  2024cites this paper
• First-in-Human Evaluation of [18F]FDOPA Produced by Organo-Photoredox Reactions.

  2024cites this paper
• Synthetic 18F labeled biomolecules that are selective and promising for PET imaging: major advances and applications.

  2024cites this paper
• Experience of 6-l-[18F]FDOPA Production Using Commercial Disposable Cassettes and an Automated Module

  2022cites this paper
• Automatic Production of [18F]F-DOPA Using the Raytest SynChrom R&D Module

  2022influential citation
• Fluorine-18: Radiochemistry and Target-Specific PET Molecular Probes Design

  2022cites this paper
• Ac-EAZY! Towards GMP-Compliant Module Syntheses of 225Ac-Labeled Peptides for Clinical Application

  2021cites this paper
• Advances in the automated synthesis of 6-[18F]Fluoro-L-DOPA

  2021cites this paper
• GMP production of 6-[18F]Fluoro-l-DOPA for PET/CT imaging by different synthetic routes: a three center experience

  2021cites this paper
• HPLC-free and cassette-based nucleophilic production of [18F]FDOPA for clinical use.

  2021cites this paper
• Production of 6-l-[18F]Fluoro-m-tyrosine in an Automated Synthesis Module for 11C-Labeling

  2021cites this paper
• State of the art of radiochemistry for 11C and 18F PET tracers

  2021cites this paper
• A generic gas chromatography method for determination of residual solvents in PET radiopharmaceuticals.

  2021cites this paper
• Research progress of 18F labeled small molecule positron emission tomography (PET) imaging agents.

  2020cites this paper
• Nucleophilic Synthesis of 6-l-[18F]FDOPA. Is Copper-Mediated Radiofluorination the Answer?

  2020cites this paper
• Synthesis and applications of 18F-labeled compounds

  2020cites this paper
• 18F-Labeled Small-Molecule and Low-Molecular-Weight PET Tracers for the Noninvasive Detection of Cancer.

  2020cites this paper
• Three-step two-pot automated production of NCA [18F]FDOPA with FlexLab module.

  2019cites this paper
• Direct arene C–H fluorination with 18F− via organic photoredox catalysis

  2019cites this paper
• 18F-labelling innovations and their potential for clinical application

  2018cites this paper
• Production of diverse PET probes with limited resources: 24 18F-labeled compounds prepared with a single radiosynthesizer

  2017cites this paper
• Fluorine-18 labelled building blocks for PET tracer synthesis.

  2017cites this paper
• A Practical Method for the Preparation of 18F-Labeled Aromatic Amino Acids from Nucleophilic [18F]Fluoride and Stannyl Precursors for Electrophilic Radiohalogenation

  2017cites this paper
• Novel immune checkpoint biomarkers for medical imaging

  year unknowncites this paper